194 related articles for article (PubMed ID: 37728697)
1. Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis.
Sargent T; Tsang Y; Panjabi S; Funtanilla V; Germack HD; Gauthier-Loiselle M; Manceur AM; Cloutier M; Lefebvre P
Adv Ther; 2023 Nov; 40(11):5037-5054. PubMed ID: 37728697
[TBL] [Abstract][Full Text] [Related]
2. Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.
Distler O; Ofner C; Huscher D; Jordan S; Ulrich S; Stähler G; Grünig E; Held M; Ghofrani HA; Claussen M; Lange TJ; Klose H; Rosenkranz S; Vonk-Noordegraaf A; Vizza CD; Delcroix M; Opitz C; Pausch C; Scelsi L; Neurohr C; Olsson KM; Coghlan JG; Halank M; Skowasch D; Behr J; Milger K; Remppis BA; Skride A; Jureviciene E; Gumbiene L; Miliauskas S; Löffler-Ragg J; Wilkens H; Pittrow D; Hoeper MM; Ewert R
Rheumatology (Oxford); 2024 Apr; 63(4):1139-1146. PubMed ID: 37462520
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of illness among patients with pulmonary arterial hypertension (PAH) associated with connective tissue disorders (CTD).
Tsang Y; Panjabi S; Funtanilla V; Germack HD; Gauthier-Loiselle M; Manceur AM; Liu S; Cloutier M; Lefebvre P
Pulm Circ; 2023 Apr; 13(2):e12218. PubMed ID: 37051491
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of endothelin receptor antagonists, alone and in combination therapy, in the pulmonary arterial hypertension-connective tissue disease subtype: A systematic review and meta-analysis.
Shivakumar S; Thynne TR; Mohammadi L; Burdeniuk C; Mangoni AA
Int J Rheum Dis; 2020 Oct; 23(10):1276-1287. PubMed ID: 32691518
[TBL] [Abstract][Full Text] [Related]
5. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis.
Kuwana M; Blair C; Takahashi T; Langley J; Coghlan JG
Ann Rheum Dis; 2020 May; 79(5):626-634. PubMed ID: 32161055
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
Cansu DÜ; Korkmaz C
Clin Rheumatol; 2023 Oct; 42(10):2601-2610. PubMed ID: 36396789
[TBL] [Abstract][Full Text] [Related]
7. The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future.
Zhao J; Wang Q; Deng X; Qian J; Tian Z; Liu Y; Li M; Zeng X
Pharmacol Ther; 2022 Nov; 239():108192. PubMed ID: 35461923
[TBL] [Abstract][Full Text] [Related]
8. Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.
Coghlan JG; Galiè N; Barberà JA; Frost AE; Ghofrani HA; Hoeper MM; Kuwana M; McLaughlin VV; Peacock AJ; Simonneau G; Vachiéry JL; Blair C; Gillies H; Miller KL; Harris JHN; Langley J; Rubin LJ;
Ann Rheum Dis; 2017 Jul; 76(7):1219-1227. PubMed ID: 28039187
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive therapy in patients with connective tissue disease-associated pulmonary arterial hypertension: A systematic review.
Ding Y; Qian J; Zhang S; Xu D; Leng X; Zhao J; Wang Q; Zhang W; Tian X; Li M; Zeng X
Int J Rheum Dis; 2022 Sep; 25(9):982-990. PubMed ID: 35699128
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary arterial hypertension in connective tissue diseases.
Goldberg A
Cardiol Rev; 2010; 18(2):85-8. PubMed ID: 20160534
[TBL] [Abstract][Full Text] [Related]
11. Hospitalization Among Pulmonary Arterial Hypertension Patients With and Without Connective Tissue Disease Comorbidities Prescribed Oral Selexipag.
Tsang Y; Singh R; Verma S; Panjabi S
Rheumatol Ther; 2023 Jun; 10(3):741-756. PubMed ID: 36959524
[TBL] [Abstract][Full Text] [Related]
12. Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset.
Channick R; Chin KM; McLaughlin VV; Lammi MR; Zamanian RT; Turricchia S; Ong R; Mitchell L; Kim NH
Cardiol Ther; 2024 Jun; 13(2):315-339. PubMed ID: 38451426
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension.
Kularatne M; Boucly A; Savale L; Solinas S; Cheron C; Roche A; Jevnikar M; Jaïs X; Montani D; Humbert M; Sitbon O
Expert Opin Pharmacother; 2023; 24(18):2101-2115. PubMed ID: 37869785
[TBL] [Abstract][Full Text] [Related]
14. Associations Between Sildenafil Use and Changes in Days of Hospitalization in a Population With Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
Yang X; Sanders KN; Mardekian J; Mychaskiw MA; Thomas J
Clin Ther; 2015 May; 37(5):1055-63. PubMed ID: 25818118
[TBL] [Abstract][Full Text] [Related]
15. 2009 ESC/ERS pulmonary hypertension guidelines and connective tissue disease.
Nakanishi N; ;
Allergol Int; 2011 Dec; 60(4):419-24. PubMed ID: 22015568
[TBL] [Abstract][Full Text] [Related]
16. Retrospective cohort study of pulmonary arterial hypertension associated with connective tissue disease effect on patients' prognosis.
Huang J; An Q; Shi H; Li C; Zhang W; Wang L
Clin Rheumatol; 2023 Nov; 42(11):3131-3142. PubMed ID: 37382842
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.
Thoreau B; Mouthon L
Autoimmun Rev; 2024 Apr; 23(4):103506. PubMed ID: 38135175
[TBL] [Abstract][Full Text] [Related]
18. Adverse Events in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
Rhee RL; Gabler NB; Praestgaard A; Merkel PA; Kawut SM
Arthritis Rheumatol; 2015 Sep; 67(9):2457-65. PubMed ID: 26016953
[TBL] [Abstract][Full Text] [Related]
19. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.
Denton CP; Humbert M; Rubin L; Black CM
Ann Rheum Dis; 2006 Oct; 65(10):1336-40. PubMed ID: 16793845
[TBL] [Abstract][Full Text] [Related]
20. Serum uric acid is associated with disease severity and may predict clinical outcome in patients of pulmonary arterial hypertension secondary to connective tissue disease in Chinese: a single-center retrospective study.
Wang J; Wang Y; Li X; Huang Y; Sun X; Wang Q; Zhang M
BMC Pulm Med; 2020 Oct; 20(1):272. PubMed ID: 33076877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]